Nazione: Svizzera
Lingua: francese
Fonte: Swissmedic (Swiss Agency for Therapeutic Products)
O-(2-hydroxyéthyl)-amylopectini hydrolysatum (130/0.4)
Fresenius Kabi (Schweiz) AG
B05AA07
O-(2-hydroxyethyl)-amylopectini hydrolysatum (130/0.4)
Solution à diluer pour perfusion
O-(2-hydroxyethyl)-amylopectini hydrolysatum (130/0.4) 30 g, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 500 ml corresp. natrium 3.61 g.
B
Synthetika
Du plasma en cas d'Hypovolémie; Hémodilution
zugelassen
2000-06-27